This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Original Research

Association Between Bone Mineral Density and Depressive Symptoms in a Population-Based Sample

Rocco D. Hlis, BS; Roger S. McIntyre, MD, FRCPC; Naim M. Maalouf, MD; Erin Van Enkevort, PhD; and E. Sherwood Brown, MD, PhD

Published: August 22, 2017

Article Abstract

Objective: This analysis was conducted to determine the relationship between bone mineral density (BMD) and depressive symptoms in a population-based cohort.

Methods: Data were extracted from the second phase of the Dallas Heart Study (DHS-2), a large, multiethnic population sample in Dallas County, Texas, from September 1, 2007, to December 31, 2009. Depressive symptom severity was measured with the 16-item Quick Inventory of Depressive Symptomatology—Self Report (QIDS-SR16), which is derived from DSM-IV major depressive disorder criteria. BMD was measured using dual-energy x-ray absorptiometry. Multiple linear regressions examined the relationship between QIDS-SR16 score and BMD controlling for age, body mass index, sex, ethnicity, smoking status, alcohol use status, serum 25-hydroxyvitamin D concentration, antidepressant use, and physical activity as measured by total vigorous and moderate metabolic equivalents. Subgroup analyses explored differences related to age.

Results: QIDS-SR16 score was not a significant predictor of either lumbar spine or total hip T-score (β = 0.01, P = .61 and β = 0.02, P = .39) in the overall population (n = 2,285). There was a significant negative interaction term between age and QIDS-SR16 group (β = 0.01, P = .01). In participants aged 60 years or older (n = 465), QIDS-SR16 score was a significant predictor of BMD at the lumbar spine and total hip (β = 0.14, P = .003 and β = 0.12, P = .006, respectively).

Conclusions: QIDS-SR16 score did not significantly predict BMD in the overall DHS-2 sample. There was, however, a significant association observed in participants aged 60 years. Results suggest that diagnosis and treatment of depressive symptoms may be of clinical importance in older individuals, a subgroup at high risk for osteoporosis and fractures.

Volume: 78

Quick Links: Depression (MDD)

Continue Reading…

Subscribe to read the entire article

$40.00

Buy this Article as a PDF

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Effect of Zuranolone on Concurrent Anxiety and Insomnia Symptoms in Women With Postpartum Depression

Zuranolone was associated with improvements in depressive and anxiety symptoms and was beneficial for insomnia and patient-perceived...

Read More...